Last updated on May 2020

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI) Immunomodulatory Drug (IMID) and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment


Brief description of study

The purpose of this study is to assess the safety and clinical response including overall response rate (ORR) of real-life standard-of-care (SOC) treatments under routine clinical practice, over a 24-month period, in patients with relapsed/refractory multiple myeloma (RRMM).

Clinical Study Identifier: NCT04035226

Find a site near you

Start Over

Az Groeninge

Kortrijk, Belgium
  Connect »

UZ Leuven

Leuven, Belgium
  Connect »

Hopital Saint-Louis

Paris cedex 10, France
  Connect »

Hopital Saint-Antoine

PARIS cedex 12, France
  Connect »

AO Cosenza

Cosenza, Italy
  Connect »

Irccs Crob

Rionero in Vulture, Italy
  Connect »

VU Medisch Centrum

Amsterdam, Netherlands
  Connect »

UMCG

Groningen, Netherlands
  Connect »

Erasmus MC - Satellite

Rotterdam, Netherlands
  Connect »

Southmead Hospital

Bristol, United Kingdom
  Connect »

Maidstone Hospital

Kent, United Kingdom
  Connect »

St George's Hospital

London, United Kingdom
  Connect »

Manchester Royal Infirmary

Manchester, United Kingdom
  Connect »

Wythenshawe Hospital

Manchester, United Kingdom
  Connect »

Marin Cancer Center

Greenbrae, CA United States
  Connect »

Central Care Cancer Center

Bolivar, MO United States
  Connect »

Optum Care

Las Vegas, NV United States
  Connect »

Hunterdon Hematology Oncology

Flemington, NJ United States
  Connect »

The Ohio State University

Columbus, OH United States
  Connect »

Novosibirsk State Medical University

Novosibirsk, Russian Federation
  Connect »

Asclepes Research

Weeki Wachee, FL United States
  Connect »

Providence Cancer Center

Southfield, MI United States
  Connect »

P le IUC Oncopole CHU

Toulouse cedex 9, France
  Connect »

City Clinical Hospital # 40

Moscow, Russian Federation
  Connect »

Nizhniy Novgorod Region Clinical Hospital

Nizhny Novgorod, Russian Federation
  Connect »

Touro Infirmary

New Orleans, LA United States
  Connect »

P le IUC Oncopole CHU

Toulouse cedex 9, France
  Connect »